Follow
Nico van Zandwijk
Nico van Zandwijk
Professor Emeritus University of Sydney
Verified email at sydney.edu.au
Title
Cited by
Cited by
Year
Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
C Schaake-Koning, W Van den Bogaert, O Dalesio, J Festen, ...
New England Journal of Medicine 326 (8), 524-530, 1992
15661992
K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung
RJC Slebos, RE Kibbelaar, O Dalesio, A Kooistra, J Stam, CJLM Meijer, ...
New England Journal of Medicine 323 (9), 561-565, 1990
9621990
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non–small-cell lung cancer
JP Van Meerbeeck, GWPM Kramer, PEY Van Schil, C Legrand, EF Smit, ...
Journal of the National Cancer Institute 99 (6), 442-450, 2007
7072007
Mutational activation of the K-ras oncogene
S Rodenhuis, ML van de Wetering, WJ Mooi, SG Evers, N van Zandwijk, ...
New England Journal of Medicine 317 (15), 929-935, 1987
6491987
Circulating microRNAs: Association with disease and potential use as biomarkers
G Reid, MB Kirschner, N van Zandwijk
Critical reviews in oncology/hematology 80 (2), 193-208, 2011
5492011
Haemolysis during sample preparation alters microRNA content of plasma
MB Kirschner, SC Kao, JJ Edelman, NJ Armstrong, MP Vallely, ...
PloS one 6 (9), e24145, 2011
5012011
EUROSCAN, a Randomized Trial of Vitamin A and N-Acetylcysteine in Patients With Head and Neck Cancer or Lung Cancer
N Van Zandwijk, O Dalesio, U Pastorino, N De Vries, H Van Tinteren
Journal of the National Cancer Institute 92 (12), 977-986, 2000
4482000
Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
U Gatzemeier, G Groth, C Butts, N Van Zandwijk, F Shepherd, A Ardizzoni, ...
Annals of oncology 15 (1), 19-27, 2004
4222004
Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
T Le Chevalier, G Scagliotti, R Natale, S Danson, R Rosell, R Stahel, ...
Lung cancer 47 (1), 69-80, 2005
3902005
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
N van Zandwijk, N Pavlakis, SC Kao, A Linton, MJ Boyer, S Clarke, ...
The Lancet Oncology 18 (10), 1386-1396, 2017
3862017
Photodynamic therapy: a promising new modality for the treatment of cancer
JJ Schuitmaker, P Baas, H Van Leengoed, FW Van der Meulen, WM Star, ...
Journal of Photochemistry and Photobiology B: Biology 34 (1), 3-12, 1996
3581996
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment …
G Giaccone, TA Splinter, C Debruyne, GS Kho, P Lianes, N Van Zandwijk, ...
Journal of clinical oncology 16 (6), 2133-2141, 1998
3251998
High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy
SCH Kao, N Pavlakis, R Harvie, JL Vardy, MJ Boyer, N van Zandwijk, ...
Clinical cancer research 16 (23), 5805-5813, 2010
3142010
Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non …
CJ Hoekstra, SG Stroobants, EF Smit, J Vansteenkiste, H Van Tinteren, ...
Journal of clinical oncology 23 (33), 8362-8370, 2005
3122005
The impact of hemolysis on cell-free microRNA biomarkers
MB Kirschner, JJB Edelman, SCH Kao, MP Vallely, N Van Zandwijk, ...
Frontiers in genetics 4, 94, 2013
2972013
Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers
CAL Ruivenkamp, T van Wezel, C Zanon, APM Stassen, C Vlcek, ...
Nature genetics 31 (3), 295-300, 2002
2902002
Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer …
G Giaccone, A Ardizzoni, A Kirkpatrick, M Clerico, T Sahmoud, ...
Journal of clinical oncology 14 (3), 814-820, 1996
2371996
Guidelines for the diagnosis and treatment of malignant pleural mesothelioma
N Van Zandwijk, C Clarke, D Henderson, AW Musk, K Fong, A Nowak, ...
Journal of thoracic disease 5 (6), E254, 2013
2322013
Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre.
MT Huizing, G Giaccone, LJ Van Warmerdam, H Rosing, PJ Bakker, ...
Journal of clinical oncology 15 (1), 317-329, 1997
2151997
Treatment of advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an European Experts Panel
C Gridelli, A Ardizzoni, T Le Chevalier, C Manegold, F Perrone, ...
Annals of oncology 15 (3), 419-426, 2004
2142004
The system can't perform the operation now. Try again later.
Articles 1–20